Araceli Biosciences’ imaging platform, which includes an automated microscope plus software that produces images of cells and measures their individual features such as size, shape and protein location. The device can rapidly analyze high volumes of cells. (Araceli Photo)
Araceli Biosciences , a Portland-area biotech company, has secured $4.5 million in funding to help commercialize technology and develop new products that support using human cells instead of animal studies to test new drugs.
The Tigard, Ore., startup offers instruments and software for creating images of cells and automating analysis. Its technologies fall under the umbrella…
Read the full article at GEEKWIRE.COM